Biomarin Pharmaceutical will report earnings after the market closes. View Calendar The market is expecting a ±11.1% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±1.9%. View Expected Move (Conf Call: Feb 23 4:30 PM)
$BMRN Earnings February 23 AMC. 20-Mar-26 Straddle Implies ±11.1% Move vs Prev. Move +1.6%
Sentiment Alert: BMRN Increasing bearish pressure with an imbalance in net option delta of -83 K.
